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AbstrAct
Objectives to document the current training, 
implementation and role of modern musculoskeletal 
imaging techniques: ultrasound, magnetic resonance 
imaging, computed tomography and positron emission 
tomography, among rheumatologists in the member 
countries of the eUlar.
Methods english-language questionnaires for each 
imaging modality developed by a eUlar task force were 
sent out to national and international scientific societies as 
well as imaging experts in the given modalities involved in 
research and/or training. the surveys were distributed via 
an online survey tool (SurveyMonkey). Simple descriptive 
and summary statistics were calculated from the 
responses.
Results More than 90% of ultrasound (US) experts 
reported the availability of a US unit in their department. 
Suspicion of rheumatoid arthritis and spondyloarthritides 
were the main clinical indications for performing US 
for diagnostic purposes. Suspicion of sacroiliitis and 
degenerative spine disease were the most common 
indications to perform magnetic resonance imaging (Mri) 
or computed tomography (ct) for diagnostic purposes, 
while positron emission tomography was mainly performed 
to diagnose large vessel vasculitis and to investigate 
fever of unknown origin. the reported percentage of 
rheumatologists performing US was highly variable, 
ranging from more than 80% in 6% of countries to less 
than 10% in 15% of countries. the majority of experts 
(77%) reported that their national rheumatology societies 
organise musculoskeletal US courses, while courses in Mri 
or ct organised by the national rheumatology societies 
were less commonly reported (29% and 8%, respectively).
Conclusions rheumatologists in europe utilise modern 
imaging techniques; however, access to the techniques 
and training offered is varied.
InTOduCTIOn
Over the past decade, emerging musculo-
skeletal imaging techniques have become 
indispensable tools both in clinical practice 
and in research in rheumatology.1 2 While 
conventional radiography is performed 
generally by radiologists (but interpreted 
also by rheumatologists), modern imaging 
methods, that is, ultrasound (US), magnetic 
resonance imaging (MRI), computed tomog-
raphy (CT) and positron emission tomog-
raphy (PET), are increasingly utilised and 
requested by rheumatologists. US machines 
are commonly applied as diagnostic and moni-
toring tools in rheumatological departments 
and private practices.3–5 While PET, CT and 
MRI are generally operated and performed 
by radiologists; there are dedicated MRI (eg, 
extremity MRI) and micro-CT units in indi-
vidual rheumatological centres solely under 
the control or catering specifically to the 
needs of rheumatology departments.6–8 In 
addition, there is a growing network of Euro-
pean centres performing research on the 
use of PET (both PET–MRI or PET–CT) in 
rheumatic diseases.9 Appropriate training is 
highly important to ensure skilled use and 
Key messages
What is already known about this subject?
 ► emerging musculoskeletal imaging techniques are 
indispensable tools both in clinical practice and in 
research in rheumatology.
What does this study add?
 ► this is the first survey on the use of ultrasound, Mri, 
ct and positron emission tomography among rheu-
matologists in eUlar countries.
 ► While modern imaging techniques are available to 
rheumatologists in eUlar countries, access to the 
techniques and training offered is varied.
How might this impact on clinical practice?
 ► Data provided by our study may help to design an 
educational strategy for eUlar.
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accurate interpretation of findings by rheumatologists. 
The EULAR has facilitated a number of educational 
efforts on modern imaging techniques, including publi-
cations on education, curriculum and competency,10–12 a 
range of online and live courses dedicated to imaging, 
a structured competency assessment system for musculo-
skeletal US (MSUS) in rheumatology ( www. eular. org), as 
well as the EULAR Imaging Library (https:// esor. eular. 
org).
The uptake and use of these techniques developed very 
differently across Europe and data are scarce and limited 
exclusively to US3–5 on their present impact on rheuma-
tology for individual European countries.13–16
The objective of this task force was, therefore, to docu-
ment the current implementation, role and training in 
modern MS imaging techniques among rheumatologists 
in EULAR countries.
MeTHOds
study design
English-language questionnaires for each imaging 
modality developed by a EULAR task force composed 
of rheumatologist experts in imaging were sent out to 
national and international organisations: (i) national 
rheumatology societies of EULAR (No.: 45); (ii) national 
societies of the European Federation of Societies for 
Ultrasound in Medicine and Biology (EFSUMB) (No.: 
29); (iii) national societies of the European Federation 
of Societies for Magnetic Resonance in Medicine and 
Biology (No.: 13) and (iv) EULAR Emerging Network 
country liaisons (No.: 45). In addition, the question-
naires were sent to European rheumatologist experts 
(201 selected as follows: persons designated by national 
societies responsible for education and training in 
imaging, contact persons/conveners of EULAR Network 
of Imaging Research and Training Centers, EFSUMB 
representatives for MSUS in rheumatology, dele-
gates (national and co-opted) of the EULAR Standing 
Committee of Musculoskeletal Imaging, faculty members 
on at least three official EULAR or EULAR-endorsed 
MSUS courses in the last 5 years, faculty members of 
the EULAR Imaging Course, and experts in CT, MRI 
and PET–CT/MRI involved in research and/or training 
known as steering committee members. The surveys were 
distributed via an online survey tool (SurveyMonkey) in 
late 2017 to early 2018. The questionnaire was accom-
panied by an explanation regarding the purpose of the 
survey. Non-responding persons and organisations were 
sent a reminder after 8, 12 and 26 weeks.
Questionnaire design
The questions contained in the questionnaires were 
divided into three broad sections: demographics, prac-
tice of imaging methods, and training and education 
in the methods available to rheumatologists. Questions 
on demographics requested information concerning 
the country of the responder. Questions on clinical 
use and on training and education requested informa-
tion concerning the country of the responder as well as 
the responder as an individual. Each survey contained 
between 41 and 45 questions, the majority of which 
were multiple choice questions, while a minority were 
simple choice or open-ended questions. With regard to 
the analysis of questions on the use of the techniques 
at the country level, in case of countries where more 
than one participant filled the questionnaire, a repre-
sentative participant (ie, respondent delegated by the 
national society or senior expert as identified by the 
steering committee) was chosen. Simple descriptive and 
summary statistics were calculated from the question-
naire responses.
ResulTs
When considering all imaging techniques combined, 
we have received a response from 34 out of 45 (76%) 
EULAR countries: 76% (34/45) for US, 69% (31/45) for 
MRI, 53% (24/45) for CT and 56% (25/45) for PET. An 
email containing the links to all four surveys were sent to 
a total of 279 imaging experts, of whom 188 filled one or 
more survey, resulting in a total number of 278 surveys 
filled. Five participants filled the same survey twice, and 
one survey was sent by a participant outside of Europe, 
therefore resulting in a final number of 272 surveys 
analysed. Distribution of respondents according to the 
country is shown in online supplementary file 1.
Musculoskeletal ultrasound
A total of 138 surveys were collected from 132 experts 
in US (five respondents filled the survey twice and one 
survey was filled by a respondent out of the region), 
from 34 out of 45 (76%) countries of EULAR. The total 
number of surveys analysed was 132. The overwhelming 
majority of respondents, 94% (124/132), were rheu-
matologists, and had ≥5 years of experience in US 
(online supplementary file 2). About 98% (129/132) 
had access to a US unit in their department and more 
than two-thirds (92/132) are certified in US by EULAR 
(online supplementary file 2). Rheumatoid arthritis 
and spondyloarthritides were the main clinical indica-
tions for performing US in their clinical practice for 
both diagnostic and management purposes (figure 1). 
The most commonly examined structures were the 
wrist, knee, shoulder, finger and ankle joints, while the 
most common target structures for US-guided interven-
tion were the shoulder, wrist, knee, elbow, ankle and 
hip (online supplementary files 3 and 4).
There was considerable variability in the percentage 
of rheumatologists performing US among the EULAR 
countries. About 29% (10/34) of participating EULAR 
countries reported that US is performed by 10%–20% 
of rheumatologists, 26% (9/34) reported that it is 
performed by 20%–40%, 18% (6/34) reported that it is 
performed by 40%–60%, 15% (5/34) reported that it is 
performed by less than 10%, 6% (2/34) reported that 
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Figure 1 Percent of patients with suspected or confirmed 
rheumatic disease in which musculoskeletal ultrasound 
is performed for diagnostic or management purposes. 
OA, osteoarthritis; RA, rheumatoid arthritis; SpA, 
spondyloarthritis.
Figure 2 Percentage of rheumatologists performing 
musculoskeletal ultrasound among member countries of the 
European League Against Rheumatism.
Figure 3 Training opportunities in musculoskeletal 
ultrasound among member countries of the European 
League Against Rheumatism. (A) Inclusion of training in 
musculoskeletal ultrasound in the national training curricula 
for rheumatologists; (B) Training course(s) in musculoskeletal 
ultrasound organised by the National Rheumatology Society 
and (C) Available levels of training in musculoskeletal 
ultrasound as provided by the National Rheumatology 
Society.
it is performed by 60%–80% and 6% (2/34) reported 
that it is performed by more than 80% of rheuma-
tologists (figure 2). Likewise, the use of US-guided 
injections was highly variable among these countries. 
About 44% (15/34) of participating EULAR countries 
reported that US-guided interventions are performed 
by 10%–20% of rheumatologists, 26% (9/34) reported 
that it is performed by less than 10% of rheumatologists, 
9% (3/34) reported that it is performed by 40%–60%, 
6% (2/34) reported that it is performed by 20%–40%, 
3% (1/34) and 3% (1/34) reported that it is performed 
by 60%–80% and more than 80%, respectively, and 9% 
(3/34) reported that it is unknown (online supplemen-
tary file 5). The percentage of rheumatologists who 
have been trained in US in EULAR countries is shown 
in online supplementary file 6. Overall, the countries 
those reported a high percentage of rheumatologists 
performing US also reported a high percentage trained 
in the method.
About 92% (121/132) of respondents educate rheu-
matologists and other specialists in the use of US and 
74% (98/132) perform research in US. Training in 
US is included in the national training curricula for 
rheumatologists in 65% (22/34) of participating coun-
tries, while competency is assessed in 70% (16/23) 
(figure 3). In the majority of countries, 68% (23/34) 
of the national rheumatology societies organises 
courses in US, the overwhelming majority of which are 
multilevel courses (figure 3). Competency, however, is 
assessed in only 54% (14/26) of such courses. Rheu-
matologists (in public and/or private practice) receive 
reimbursement for US in 62% (30/34) of countries. In 
15% (5/34) of countries, there are national registers 
of rheumatologists performing US and 53% (18/34) 
reported that there is a committee/subgroup in the 
national society of rheumatology responsible for prac-
tice and/or training in US.
Magnetic resonance imaging
A total of 55 surveys from 55 experts in MRI from 31 
out 45 (69%) EULAR countries were collected and 
analysed. The overwhelming majority of respondents, 
85% (45/55), were rheumatologists, and had ≥5 years 
of experience in reading MRI (online supplementary 
file 7). About 75% (41/55) of experts had access to an 
MRI unit in another department (eg, radiology) in their 
centre, and 22% reported having an MRI unit in their 
department (12/55 respondents, 6 of whom, however, 
were radiologists) (online supplementary file 7). About 
47% (26/55) of respondents reported that their MRI 
is read by a radiologist, 40% (22/55) reported that 
both the radiologist and the rheumatologist read the 
MRI and only 13% (7/55) reported reading the MRI 
themselves (online supplementary file 7). In clinical 
practice, the respondents reported local or joint-level 
diagnosis followed by global or patient-level diagnosis, 
and making decisions on systemic therapy as the most 
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Figure 4 Percent of patients with suspected or confirmed 
rheumatic disease in which MRI is performed for diagnostic 
or management purposes. SpA, spondyloarthritis.
Figure 5 Percentage of rheumatologists reading MRI 
(A) and CT (B) among member countries of the European 
League Against Rheumatism.
common reasons for requesting musculoskeletal MRI 
(online supplementary file 8). With regard to medical 
conditions, sacroiliitis and degenerative spine disease 
are the most common indications to request MRI 
for both the diagnostic and management purposes 
(figure 4). About 53% (29/55) of respondents educate 
rheumatologists and other specialists in the use of MRI 
and 56% (31/55) perform research in MRI.
The majority of participating EULAR countries, 65% 
(20/31), reported that 80%–100% of rheumatology 
departments in the country have access to MRI, and 
only 13% (4/31) reported less than 10% of rheuma-
tology departments having access to MRI (figure 5). 
Training in MRI is included in the national training 
curricula for rheumatologists in only 10% (3/31) of 
participating countries, and competency is not assessed. 
About 29% (9/31) of national rheumatology societies 
of EULAR countries organise courses in MRI; however, 
competency is assessed in only 17% (2/12) of coun-
tries (online supplementary file 9). A single country 
(Serbia) reported that rheumatologists receive reim-
bursement for reading MRI in private practice. None 
of the countries reported having a national register 
of rheumatologists reading MRI. Three countries 
(Austria, Netherlands and Poland) reported having a 
committee/subgroup in the national society of rheu-
matology responsible for practice and/or training in 
MRI.
computed tomography (including dual-energy and micro-
computed tomography)
A total of 39 surveys from 39 experts from 24 out of 45 
(53%) countries of EULAR were collected and analysed. 
The majority of respondents 90% (35/39), were rheuma-
tologists, and had ≥5 years of experience in this imaging 
modality (online supplementary file 10).
About 85% (33/39) reported having easy access to a 
CT unit in another department (eg, radiology depart-
ment) in their centre, 10% reported having a CT unit 
in their department (four respondents, three of whom, 
however, were radiologists) and 5% (2/39) reported 
having no access to CT (online supplementary file 10). 
About 69% (27/39) of respondents reported that their 
CT is read by a radiologist, 21% (8/39) reported that 
both the radiologist and the rheumatologist read the CT 
and only 10% (4/39) reported reading the CT them-
selves (online supplementary file 10). Sacroiliitis and 
degenerative spine disease are the most common indica-
tions to request CT for both the diagnostic and manage-
ment purposes (online supplementary file 11).
The majority of participating EULAR countries, 63% 
(15/24), who responded to our survey, reported that 
80%–100% of rheumatology departments in the country 
have access to CT, and only 4% (1/24) reported that less 
than 10% of rheumatology departments have access to 
CT (figure 5). Training in CT is included in the national 
training curricula for rheumatologists in only 4% (1/24) 
of participating countries (competency is not assessed), 
and only 8% (2/24) of national rheumatology societies 
of EULAR countries organise courses in CT (competency 
is not assessed) (online supplementary file 12).
Positron emission tomography
A total of 46 surveys from 46 experts in PET (both PET/
MRI and/or PET/CT) from 25 out of 45 (56%) EULAR 
countries were collected and analysed. The majority of 
respondents, 80% (37/46), were rheumatologists, and 
had ≥5 years of experience in this imaging modality 
(either performing the technique in their department 
or collaborating with a centre performing PET (eg, 
nuclear medicine department) (online supplementary 
file 13). The overwhelming majority of experts, 95% 
(41/43), utilise PET–CT, 9% (4/43) utilise PET–MRI 
and 12% (5/43) utilise standalone PET (respondents 
were allowed to indicate more than one option). About 
93% (39/42) of experts request or perform whole-body 
PET, while 10% (4/42) reported targeted examinations 
(eg, detailed scans of joints or spine/pelvis depending on 
the research question or clinical indication). Large vessel 
vasculitis, fever or increased erythrocyte sedimentation 
rate of unknown origin were the most common indica-
tions to request PET for diagnostic purposes (figure 6). 
For the purpose of decisions on systemic therapy, large 
vessel vasculitis was the most commonly reported indica-
tion (figure 6). Other indications not listed but reported 
by the experts included sarcoidosis, immunoglobulin 
G4-related disease, total joint replacement, constitutional 
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Figure 6 Percent of patients with suspected rheumatic 
disease in which positron emission tomography is performed 
for diagnostic purposes or for making decisions on systemic 
therapy. ESR, erythrocyte sedimentation rate; LVV, large 
vessel vasculitis.
symptoms, suspicion of malignancy, polymyalgia rheu-
matica and suspicion of osteomyelitis. About 52% 
(24/46) of respondents reported doing research in PET. 
The majority of experts, 80% (38/46), reported having 
no access to training courses in PET. Access to PET tech-
nique was varied in EULAR countries (online supple-
mentary file 14).
dIsCussIOn
This is the first survey aiming to encompass all modern 
imaging methods commonly utilised by rheumatologists 
in EULAR countries. While there have been previous 
surveys focusing on the use of US in European countries3–5 
by rheumatologists, no survey has been performed on the 
use of other techniques, such as MRI, CT and PET, among 
rheumatologists. By including questions concerning both 
national societies and individual responders, the surveys 
allowed us to gain an understanding of both practice and 
training in the techniques. When considering the distri-
bution and number of participants who have filled our 
survey, with some exceptions, this corresponds roughly 
to activity in imaging research and education among the 
different countries.
Compared with the previous surveys on MSUS,3 4 the 
results of our survey demonstrate a growing uptake in 
the use of MSUS by rheumatologists, both in terms of 
rheumatologists performing MSUS, as well as MSUS-
guided interventions, as well as in the training in both 
the MSUS and MSUS-guided interventions.3 In 2010, 
56% of EULAR countries who participated in the survey 
reported less than 10% of rheumatologists performing 
MSUS routinely as compared with 15% reporting less 
than 10% in our current study (figure 2).3 In 2009–2010, 
MSUS was an obligatory or optional/recommended 
part of the curricula in 23%–35% of EULAR countries, 
being competency, however, assessed in only 19%.3 
Currently, training in MSUS is included in the national 
training curricula in 65% of participating countries, 
while competency is assessed in 70% (figure 3A and B). 
About 68% of national rheumatology societies organises 
courses in MSUS, the overwhelming majority of which 
are multilevel courses, as compared with 40% of coun-
tries reported in our previous study, mostly consisting of 
one-level training4 (3C). Competency is assessed in 54% 
of courses, up from 20%.4
CT and MRI are generally accessible to rheumatol-
ogists in most EULAR countries, while access to PET is 
varied. Only a small fraction of rheumatologists read 
their MRIs and CTs themselves, although a sizeable frac-
tion reported reading these examinations in addition to 
being read by radiologists. This scenario may be related 
to the fact that, compared with US, training in MRI, CT 
or PET is still quite limited for rheumatologists. Further 
efforts in education in these imaging modalities, which 
have become essential in the field of rheumatology, 
would possibly facilitate the more efficient use of these 
techniques by rheumatologists in clinical practice.
Our survey shows an updated overview on the use of 
imaging by rheumatologists in Europe with a consider-
able representation of experts and countries. Certain 
limitations, however, could not be avoided. Due to the 
fact that we surveyed imaging experts, participation bias 
could not be avoided, which may have led to an overesti-
mation of the use and impact of modern imaging methods 
in rheumatology. Additionally, the high interest among 
responders in a given imaging technique (in partic-
ular, CT, MRI and PET, which are generally not directly 
controlled by rheumatologists) could have also led to 
overestimated or skewed practice characteristics within 
the countries. Despite a good overall response, a number 
of countries have not provided information, and in many 
countries, we received information from only single 
experts in a given imaging technique, which introduces 
bias to the results. In order to enhance the response rate, 
we had to limit the overall length and themes covered 
by the surveys, which meant that we could not explore 
among others, the use of imaging in paediatric rheu-
matology. Furthermore, we did not collect data on the 
type or technical level of imaging equipment available, 
which would have enriched the results on implementa-
tion. More detailed queries on available courses and the 
quality and quantity of training required by the national 
curricula may have provided more insight into training 
in imaging methods.
EULAR has recently launched a number of initiatives 
those provide training in modern imaging techniques. 
These include the EULAR Online Course on Imaging 
in Rheumatic and Musculoskeletal Diseases; participants 
of this course also have the option to attend the EULAR 
Advanced Hands-On Imaging Workshop, a practical 
case-based event prior to the EULAR Annual Congress. 
In addition, EULAR also organises the EULAR Imaging 
Course, a comprehensive new course on conventional 
radiography, MRI, CT and MSUS. For the past 25 years, 
EULAR has been offering its own multilevel US course 
and also endorses numerous courses in MSUS world-
wide. Nevertheless, based on the results of our survey, we 
can certainly conclude that a greater offer of training in 
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imaging modalities (particularly non-MSUS) would be 
beneficial to improve the utilisation and use of modern 
imaging techniques among rheumatologists in Europe.
In conclusion, data provided by this survey may help 
to design an educational strategy for EULAR aiming at 
achieving homogeneous, high-quality performance and 
use of modern imaging modalities across its member 
countries, which is consistent with, and would enhance 
the mission of this organisation.
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